November 30, 2021 — The emergence of the omicron coronavirus variant is sparking fresh calls for vaccine equity, including calls to temporarily waive patents around vaccine production. Pauline Worsfold, a registered nurse and a member of the Canadian Federation of Nurses Unions, explains why waiving the patent will help ramp up vaccine production. We also talk about the big picture with Dr. Githinji Gitahi, Global CEO of Amref Health Africa; and Dr. Wafaa El-Sadr, an epidemiologist and the director of ICAP at Columbia University.